[Tolerance of the gestagen-estrogen combination Noracyclin in contraception and gynecologic indications].
D000328:Adult; D001835:Body Weight / Q000187:drug effects; D003267:Contraception; D004357:Drug Synergism; D004361:Drug Tolerance; D004715:Endometriosis / Q000188:drug therapy; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use*; D008599:Menstruation Disturbances / Q000188:drug therapy; D008656:Mestranol / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D010060:Ovulation / Q000187:drug effects; D011293:Premenstrual Syndrome / Q000188:drug therapy; D014591:Uterine Diseases / Q000188:drug therapy
D004997:Ethinyl Estradiol; D008656:Mestranol; D008234:Lynestrenol
Verträglichkeit der Gestagen-Ostrogen-Kombination Noracyclin bei Kontrazeption und gynäkologischen Indikationen.